| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Robin J Borchert, Timothy Rittman, Charlotte L Rae, Luca Passamonti, Simon P Jones, Deniz Vatansever, Patricia Vázquez Rodríguez, Zheng Ye, Cristina Nombela, Laura E Hughes, Trevor W Robbins, James B Row. Atomoxetine and citalopram alter brain network organization in Parkinson's disease. Brain communications. vol 1. issue 1. 2021-09-24. PMID:31886460. |
recent evidence has shown potential benefits from restoring other neurotransmitter deficits, including noradrenergic and serotonergic transmission. |
2021-09-24 |
2023-08-13 |
Not clear |
| Benjamin Vidal, Elise Levigoureux, Sarah Chaib, Caroline Bouillot, Thierry Billard, Adrian Newman-Tancredi, Luc Zimme. Different Alterations of Agonist and Antagonist Binding to 5-HT1A Receptor in a Rat Model of Parkinson's Disease and Levodopa-Induced Dyskinesia: A MicroPET Study. Journal of Parkinson's disease. vol 11. issue 3. 2021-09-23. PMID:33998548. |
serotonergic neurons are partially responsible for this, by converting l-dopa into dopamine leading to its uncontrolled release as a "false neurotransmitter". |
2021-09-23 |
2023-08-13 |
rat |
| Bing Xiao, Fang Han, Yuxiu Sh. Administration of moclobemide facilitates fear extinction and attenuates anxiety-like behaviors by regulating synaptic-associated proteins in a rat model of post-traumatic stress disorder. Synapse (New York, N.Y.). vol 74. issue 6. 2021-07-29. PMID:31869485. |
dysfunction of the serotonergic neurotransmitter system is involved in numerous mental and behavioral disorders. |
2021-07-29 |
2023-08-13 |
rat |
| Atoossa Fahimi, Mahjabin Noroozi, Ahmad Saleh. Enlargement of early endosomes and traffic jam in basal forebrain cholinergic neurons in Alzheimer's disease. Handbook of clinical neurology. vol 179. 2021-07-28. PMID:34225963. |
while a handful of neurotransmitter systems including cholinergic, norepinephrinergic, and serotonergic undergo significant degeneration in alzheimer's disease, the cholinergic system has been the prime target for research and therapy. |
2021-07-28 |
2023-08-13 |
Not clear |
| Mathis Hildonen, Amanda M Levy, Christina Dahl, Victoria A Bjerregaard, Lisbeth Birk Møller, Per Guldberg, Nanette M Debes, Zeynep Tüme. Elevated Expression of Genes. vol 12. issue 1. 2021-07-21. PMID:33445578. |
several neurotransmitter systems have been implicated in disease pathogenesis, and amongst these, the dopaminergic and the serotonergic pathways are the most widely studied. |
2021-07-21 |
2023-08-13 |
Not clear |
| Juergen Dukart, Stefan Holiga, Michael Rullmann, Rupert Lanzenberger, Peter C T Hawkins, Mitul A Mehta, Swen Hesse, Henryk Barthel, Osama Sabri, Robert Jech, Simon B Eickhof. JuSpace: A tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps. Human brain mapping. vol 42. issue 3. 2021-07-14. PMID:33079453. |
based on this approach, we introduce a toolbox (juspace) allowing for cross-modal correlation of mri-based measures with nuclear imaging derived estimates covering various neurotransmitter systems including dopaminergic, serotonergic, noradrenergic, and gabaergic (gamma-aminobutric acid) neurotransmission. |
2021-07-14 |
2023-08-13 |
Not clear |
| Alok Joshi, Da-Hui Wang, Steven Watterson, Paula L McClean, Chandan K Behera, Trevor Sharp, KongFatt Wong-Li. Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's disease. Neuropharmacology. vol 174. 2021-07-07. PMID:32380022. |
over the last decade, there has been increased attention towards novel drugs, targeting alternative neurotransmitter pathways, particularly those targeting serotonergic (5-ht) system. |
2021-07-07 |
2023-08-13 |
Not clear |
| Bichu Cheng, Johannes Morstein, Lucy Kate Ladefoged, Jannick Bang Maesen, Birgit Schiøtt, Steffen Sinning, Dirk Traune. A Photoswitchable Inhibitor of the Human Serotonin Transporter. ACS chemical neuroscience. vol 11. issue 9. 2021-06-18. PMID:32275382. |
the human serotonin transporter (hsert) terminates serotonergic signaling through reuptake of neurotransmitter into presynaptic neurons and is a target for many antidepressant drugs. |
2021-06-18 |
2023-08-13 |
human |
| Murugesan Pooranachithra, Chelladurai Satheesh Kumar, James Prabhanand Bhaskar, Krishnan Venkateswaran, Velayutham Ravichandiran, Krishnaswamy Balamuruga. Proteomic analysis of Caenorhabditis elegans wound model reveals novel molecular players involved in repair. Journal of proteomics. vol 240. 2021-06-18. PMID:33831597. |
initial gel-based 2-d ge and following protein-protein interaction (ppi) network analyses revealed active role of calcium signaling, acetylcholine transport and serotonergic neurotransmitter pathways. |
2021-06-18 |
2023-08-13 |
caenorhabditis_elegans |
| Hera Wu, DeVon Herr, Nancie J MacIver, Jeffrey C Rathmell, Valerie A Gerriet. CD4 T cells differentially express cellular machinery for serotonin signaling, synthesis, and metabolism. International immunopharmacology. vol 88. 2021-05-25. PMID:32866787. |
5-ht is well known as a neurotransmitter and recently has been recognized to play a role in the immune response; however, little is known about the immune cell type-specific expression of the serotonergic machinery and receptors. |
2021-05-25 |
2023-08-13 |
Not clear |
| Delaram Eslimi Esfahani, Mohammad Reza Zarrindas. Cholestasis and behavioral disorders. Gastroenterology and hepatology from bed to bench. vol 14. issue 2. 2021-05-13. PMID:33968336. |
it has been reported that after he, all classical neurotransmitter systems such as opioidergic, dopaminergic, cholinergic, gabaergic, adrenergic, serotonergic, and glutamatergic systems can be altered. |
2021-05-13 |
2023-08-13 |
Not clear |
| Ria Fisher, Atsuko Hikima, Rebecca Morris, Michael J Jackson, Sarah Rose, Mark A Varney, Ronan Depoortere, Adrian Newman-Tancred. The selective 5-HT Neuropharmacology. vol 167. 2021-04-23. PMID:32057799. |
the selective 5-ht l-dopa is the gold-standard pharmacotherapy for treatment of parkinson's disease (pd) but can lead to the appearance of troubling dyskinesia which are attributable to 'false neurotransmitter' release of dopamine by serotonergic neurons. |
2021-04-23 |
2023-08-13 |
Not clear |
| Namhun Lee, Se-Jong Oh, Jang-Woo Park, Kyung-Rok Nam, Kyung-Jun Kang, Kyo-Chul Lee, Yong-Jin Lee, June-Seek Choi, Jeong-Ho Seok, Jae-Yong Cho. Evaluation of the Effects of Developmental Trauma on Neurotransmitter Systems Using Functional Molecular Imaging. International journal of molecular sciences. vol 22. issue 5. 2021-04-22. PMID:33802338. |
of neurotransmitter systems analyzed, the rate of decrease in brain uptake was the highest in the serotonergic group. |
2021-04-22 |
2023-08-13 |
Not clear |
| Mohammad Naderi, Pankaj Puar, Mahtab Zonouzi-Marand, Douglas P Chivers, Som Niyogi, Raymond W M Kwon. A comprehensive review on the neuropathophysiology of selenium. The Science of the total environment. vol 767. 2021-02-26. PMID:33445002. |
a wealth of evidence has shown that exposure to excess se may compromise the normal functioning of various key proteins, neurotransmitter systems (the glutamatergic, dopaminergic, serotonergic, and cholinergic systems), and signaling molecules involved in the control and regulation of cognitive, behavioral, and neuroendocrine functions. |
2021-02-26 |
2023-08-13 |
Not clear |
| Meng Li, Jiaping Zhu, Hua Fang, Mengcen Wang, Qiangwei Wang, Bingsheng Zho. Coexposure to environmental concentrations of cis-bifenthrin and graphene oxide: Adverse effects on the nervous system during metamorphic development of Xenopus laevis. Journal of hazardous materials. vol 381. 2020-11-12. PMID:31425913. |
exposure to cis-bf and go caused further reduction in pre-metamorphic developmental rates and activated dopaminergic, noradrenergic, and serotonergic neurotransmitter systems. |
2020-11-12 |
2023-08-13 |
xenopus_laevis |
| Ayse Akhan, Ferhunde Dilek Subasi, Gulsen Bosna, Osman Ekinci, Hakan Pamuk, Siddika Batan, Rezzan Yagmur Ateser, Gulden Tura. Comparison of mirtazapine, gabapentin and ondansetron to prevent intrathecal morphine-induced pruritus. Northern clinics of Istanbul. vol 3. issue 1. 2020-10-01. PMID:28058386. |
antagonism of the central nervous system inhibitor neurotransmitter gamma-aminobutyric acid (gaba) or serotonergic system activation is an important factor in the pathogenesis of intrathecal morphine-induced pruritus. |
2020-10-01 |
2023-08-13 |
Not clear |
| Anand Venkatraman, Brian L Edlow, Mary Helen Immordino-Yan. The Brainstem in Emotion: A Review. Frontiers in neuroanatomy. vol 11. 2020-10-01. PMID:28337130. |
finally, the brainstem is home to a group of modulatory neurotransmitter pathways, such as those arising from the raphe nuclei (serotonergic), ventral tegmental area (dopaminergic) and locus coeruleus (noradrenergic), which form a modulatory network that coordinates interactions between the ascending and descending networks. |
2020-10-01 |
2023-08-13 |
human |
| Ahmed Al-Qassabi, Seyed-Mohammad Fereshtehnejad, Ronald B Postum. Sleep Disturbances in the Prodromal Stage of Parkinson Disease. Current treatment options in neurology. vol 19. issue 6. 2020-10-01. PMID:28466429. |
disturbances in serotonergic, cholinergic, dopaminergic, and glutamatergic neurotransmitter systems have made sleep disorders potential candidates for prodromal pd. |
2020-10-01 |
2023-08-13 |
Not clear |
| Ansley Stanfill, Claire Simpson, Paula Sherwood, Samuel Poloyac, Elizabeth Crago, Hyungsuk Kim, Yvette Conle. A pilot study on the impact of dopamine, serotonin, and brain-derived neurotrophic factor genotype on long-term functional outcomes after subarachnoid hemorrhage. SAGE open medicine. vol 5. 2020-10-01. PMID:28894586. |
many that survive an aneurysmal subarachnoid hemorrhage experience lasting physical disability, which might be improved by medications with effects on the dopaminergic, serotonergic, and brain-derived neurotrophic factor neurotransmitter systems. |
2020-10-01 |
2023-08-13 |
Not clear |
| Chee Lee, Ginevra Liptan, Svetlana Kantorovich, Maneesh Sharma, Ashley Brento. Association of Catechol- BMC rheumatology. vol 2. 2020-10-01. PMID:30886988. |
fm is considered to have a genetic background due to its familial aggregation and due to findings from multiple candidate-gene studies implicating catecholaminergic and serotonergic neurotransmitter systems in chronic pain. |
2020-10-01 |
2023-08-13 |
Not clear |